Thus, restoration of WT p53 function at least partially sensitized pancreatic tumor cells to MEK inhibition; however, expression of the specific Trp53R270H mutant did not change response to combined MEK and PI3K inhibition, compared with other pancreatic cancer cell lines. The gene discussed is TP53; the disease is pancreatic neoplasm.